Summary
Background Fluconazole-resistant Candida parapsilosis has emerged as a significant healthcare-associated pathogen with a propensity to spread patient-to-patient and cause nosocomial outbreaks, similar to Candida auris. This study investigates a prolonged outbreak of fluconazole-resistant C. parapsilosis across multiple years and healthcare centers in Berlin, Germany.
Methods In this retrospective observational study, we used whole-genome sequencing of isolates from the outbreak in Berlin and other regions within Germany and compared them with isolates from a global distribution to understand the molecular epidemiology of this outbreak. Additionally, we used the genomic dataset of global samples to identify loci with high discriminatory power to establish a multi-locus sequence typing (MLST) strategy for C. parapsilosis.
Findings A clonal, azole-resistant strain of C. parapsilosis was observed causing 33 cases of invasive infection from 2018-2022 in multiple hospitals within the outbreak city. Whole genome sequencing revealed that outbreak strains were separated by an average of 36 single nucleotide variants, while outbreak strains differed from outgroup samples from Berlin and other regions of Germany by an average of 2,112 variants. Temporal and genomic reconstruction of the outbreak cases indicated that transfer of patients between healthcare facilities was likely responsible for the persistent reimportation of the drug-resistant clone and subsequent person-to-person transmission. German outbreak strains were closely related to strains responsible for an outbreak in Canada and to others isolated in the Middle East and East Asia. Including the outbreak clone, we identified three distinct ERG11 Y132F azole-resistant lineages in Germany, marking the first description of this azole-resistance in the country and its endemic status. Using the novel MLST strategy, a global collection of 386 isolates was categorized into 62 sequence types, with the outbreak strains all belonging to the same sequence type.
Interpretation This study underscores the emergence of drug resistant fungal pathogens that can spread patient-to-patient within a healthcare system, but also around the globe. This highlights the importance of monitoring C. parapsilosis epidemiology globally and of continuous surveillance and rigorous infection control measures at the local scale. Through large-scale genomic epidemiology, our study offers a high-resolution view of how a drug-resistant clone behaved in a local healthcare system and how this clone fits into the global epidemiology of this pathogen. We also demonstrate the utility of the novel typing scheme for genetic epidemiology and outbreak investigations as a faster and less expensive alternative to whole genome sequencing.
Funding German Federal Ministry for Education and Research, German Research Foundation, German Ministry of Health
Evidence before this study We searched PubMed and Google Scholar from database inception to Apr 25, 2024, using the search terms “Candida parapsilosis”, “outbreak”, “azole resistance”, and/or “fluconazole” in PubMed and Google Scholar. We applied no language or study type restrictions. The epidemiology of candidemia has undergone dramatic changes in recent years. New pathogenic species, such as Candida auris, have emerged, and existing species like Candida parapsilosis have increased in prominence. There has also been a worrying increase in drug resistance among Candida species. Moreover, numerous drug-resistant outbreaks of C. parapsilosis have been reported worldwide and are challenging to control due to their prolonged and intermittent nature. The overwhelming majority of previous work has used microsatellite markers to infer genetic relationships among outbreaks strains, obscuring whether they are really clonal in nature, our understanding of the temporal and transmission dynamics of these outbreaks, and the genetic relationship between outbreak clones.
Added value of this study This study adds to the existing evidence by utilizing whole genome sequencing in conjunction with hospital records to analyze a prolonged outbreak of clonal, azole-resistant C. parapsilosis that occurred across multiple years and medical centers. This study demonstrates that patient transfers can result in the reimportation of outbreak clones, posting a significant challenge for infection control. We also reveal that the outbreak clone is closely related to drug-resistant isolates from other continents, highlighting the global spread of drug-resistant C. parapsilosis. Furthermore, the study addresses the need for rapid strain differentiation in outbreak settings by establishing and validating a set of four loci for Sanger sequence-based typing, which provide a highly discriminatory tool for epidemiologic investigations.
Implications of all the available evidence This study underscores the global challenge of azole-resistant C. parapsilosis and its importance as the causative agent of nosocomial outbreaks. Clinicians should be aware of the evolving epidemiology of C. parapsilosis and the prevalence of drug-resistant strains, emphasizing the importance of appropriate antifungal stewardship and infection control measures. The study emphasizes the challenges caused by inter-hospital transmission and their role in persistent outbreaks, highlighting the need for robust surveillance and coordination among healthcare facilities. While whole genome sequencing (WGS) is becoming more widely available, it is still not available in many settings due to cost, limitations in bioinformatic expertise, and the absence of standardized methodology and data interpretation. The establishment of a sequence-based typing scheme is a valuable tool for rapid assessment of samples, which can aid in outbreak tracking and containment efforts, and provide results more rapidly even in settings where WGS is available.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by The Federal Ministry for Education and Science (Bundesministerium fuer Bildung und Forschung) within the framework of InfectControl 2020 (Projects FINAR 2.0, grant 03ZZ0834). The work of the German National Reference Center for Invasive Fungal Infections is supported by the Robert Koch Institute from funds provided by the German Ministry of Health (grant 1369-240). AEB is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under its Excellence Strategy, EXC 20151, Project ID 390813860.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the University Hospital Jena approved this study under registration number 2024-3255-Daten.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Based on reviewer feedback, we incorporated additional public sequence data in our revised manuscript, including a recently published C. parapsilosis outbreak in Canada (doi: 10.1128/jcm.01161-23) bringing our study dataset from 258 to 381 samples. Through this, we discovered that the German outbreak isolates are closely related to those from an outbreak in Canada. We were also able to obtain antifungal histories for the majority of cases to strengthen the clinical aspects of our study. Finally, we observed that a possible typing locus that we had previously considered and experimentally validated, but not selected in our first submission, yielded a slight improvement in discriminatory power in the larger dataset compared to the four from our original submission. In light of this, we have replaced one of the original four loci with a different locus in our revision.
Data Availability
Raw FASTQ files for novel isolates sequenced in this study were uploaded to the NCBI Sequence Read Archive and are publicly available under BioProject PRJNA996760. Accession numbers for the publicly available sequence data used in this study are listed in appendix 2. Genbank records for the Sanger sequencing of the MLST loci performed in this study are listed in appendix 1 p 14. FASTAs containing representative allele sequences for each of the four typing loci are available as appendices 4-7.
